Pathways’ Picks January 6: Medtech Takeaways from Georgia, London, and Beijing

article image

In this week’s roundup: A look at the medtech implications from the Georgia Senate run-offs, marking the full coming of Brexit, regulatory news from China and India, and more to watch at FDA, CMS, and on Capitol Hill.

Democrats take Senate control. Brexit becomes reality. COVID-19 carries on, as global agencies try to branch out to more non-emergency policymaking. Welcome to 2021. Here’s what you need to know in the medtech realm in this first full week of the new year.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: